Transarterial Chemoembolization (tace) - Histology

Relevant Publications

Biodegradable Microembolics with Nanografted Polyanions Enable High-Efficiency Drug Loading and Sustained Deep-Tumor Drug Penetration for Locoregional Chemoembolization Treatment.

Issue Release: 2024

Comparison of efficacy and safety of conventional transarterial chemoembolization and drug-eluting bead transarterial chemoembolization in unresectable intrahepatic cholangiocarcinoma: A multicenter retrospective cohort study.

Issue Release: 2024

[Multiparametric MRI in hepatocellular carcinoma, part 2 : Diffusion-weighted imaging in the primary diagnostics and treatment monitoring].

Issue Release: 2024

Lipiodol combined with drug-eluting beads versus drug-eluting beads alone for transarterial chemoembolization of hepatocellular carcinoma: a multicenter study.

Issue Release: 2024

Transarterial embolization is an acceptable bridging therapy to hepatocellular carcinoma prior to liver transplantation.

Issue Release: 2024

Efficacy of transarterial chemoembolization treatment with 30-60-μm microspheres in patients with hepatocellular carcinoma.

Issue Release: 2024

Survival in Patients With Recurrent Intermediate-Stage Hepatocellular Carcinoma: Sorafenib Plus TACE vs TACE Alone Randomized Clinical Trial.

Issue Release: 2024

Machine learning-based model for predicting tumor recurrence after interventional therapy in HBV-related hepatocellular carcinoma patients with low preoperative platelet-albumin-bilirubin score.

Issue Release: 2024

Lenvatinib plus drug-eluting bead transarterial chemoembolization with/without hepatic arterial infusion chemotherapy for hepatocellular carcinoma larger than 7 cm with major portal vein tumor thrombosis: a multicenter retrospective cohort study.

Issue Release: 2024

Transarterial chemoembolization with I seed insertion for multifocal hepatocellular carcinoma.

Issue Release: 2024

The long-term efficacy and safety of apatinib are inferior to sorafenib in the first-line treatment of advanced hepatocellular carcinoma: A systematic review and meta-analysis.

Issue Release: 2024

A Rare Early-Onset Fatal Complication after Transarterial Chemoembolization: A Case Report and Review of the Literature.

Issue Release: 2024

Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma.

Issue Release: 2024

Safety, efficacy, and survival of different transarterial chemoembolization techniques in the management of unresectable hepatocellular carcinoma: a comparative single-center analysis.

Issue Release: 2024

Efficacy and Safety of CT-guided Percutaneous Cryoablation for Hepatocellular Carcinoma at High-risk Sites.

Issue Release: 2024

Multiple asynchronous recurrence as a predictive factor for refractoriness against locoregional and surgical therapy in patients with intermediate-stage hepatocellular carcinoma.

Issue Release: 2024

Predicting Survival Using Whole-Liver MRI Radiomics in Patients with Hepatocellular Carcinoma After TACE Refractoriness.

Issue Release: 2024

Assessment of safety and efficacy of transarterial chemoembolization combined with camrelizumab and donafenib in patients with hepatocellular carcinoma at BCLC stage C: A study of 20 cases.

Issue Release: 2024

Options and survival benefits of conversion therapy for unresectable hepatocellular carcinoma.

Issue Release: 2024

[Radiologically guided interventional therapies for the treatment of neuroendocrine tumors].

Issue Release: 2024

How Do Lysozymes Function?

What Are Some Examples of Open Data Initiatives in Histology?

What are DNA Breaks?

What is Dual Energy X-ray Absorptiometry (DXA)?

Why are Quality Control Materials Important?

What is Glutamate Decarboxylase (GAD)?

What Are Some Applications of Antibody Staining?

What is Polyclonal?

What is the role of mitochondria in energy storage and metabolism?

What is Genomic Stability?

Transarterial Chemoembolization (tace) - Histology

Relevant Publications

Partnered Content Networks

Relevant Topics